Prediction in colorectal cancer using proteomics

  • G. A
  • U.J. R
  • T. R
  • et al.
Citations of this article
Mendeley users who have this article in their library.


Background: Colorectal cancer is the second leading cause of cancer related death. Current clinical practice in colorectal cancer screening (FOBT, Colonoscopy) has contributed to a reduction of mortality. However, despite these screening programs, about 70% of carcinomas are detected at advanced tumor stages (UICC III/IV) presenting poor patient prognosis. Thus, innovative tools and methodologies for early cancer detection can directly result in improving patient survival rates. Methods: Here we report our results of a comprehensive approach for colorectal cancer biomaker identification in tissue and blood with a main emphasis on two-dimensional gelelectrophoresis (2- DE) and mass-spectrometry analyses. Results: Proteomics-based technologies enable to identify single proteins and groups of proteins, including isoforms and post-translationally modified variants that are highly correlated to malignant transformation and clinical tumor aggressiveness. In addition, our 2-DE data strongly indicate that macroscopically and microscopically uneffected mucosa of patients later developing familial adenomatous polyposis (FAP) exhibit a specific protein expression pattern, which may allow to diagnose the disease at its earliest stage. This observation indicates for the first time a possibility to discriminate between clinically silent and clinically active hereditary disease. Furthermore, the detection of serum-based protein expression pattern that allow distinction of healthy and diseased patients in the peripheral blood can ameliorate existing screening programs in a minimally-invasive and patient friendly fashion. Conclusions: Proteomics-based technologies could greatly improve common classification systems, diagnostics and prediction. However, this progress has not yet transferred from bench to bedside but could open the door to a more accurate and target specific personalized medicine with improved patient survival.




G., A., U.J., R., T., R., & J.K., H. (2010). Prediction in colorectal cancer using proteomics. Cellular Oncology. G. Auer, Karolinska Biomic Center (KBC), Karolinska Institutet, Stockholm, Sweden: IOS Press. Retrieved from

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free